S1-Leitlinie: Nichtorganische Schlafstörungen (F51). In: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF). Deutsche Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie e.V. (DGKJP), November 2021, abgerufen am 3. August 2022.
Alexander A. Borbély, Serge Daan, Anna Wirz‐Justice, Tom Deboer: The two‐process model of sleep regulation: a reappraisal. In: Journal of Sleep Research. Band25, Nr.2, April 2016, S.131–143, doi:10.1111/jsr.12371.
Dun-Xian Tan, Lucien Manchester, Lilan Qin, Russel Reiter: Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics. In: International Journal of Molecular Sciences. Band17, Nr.12, 16. Dezember 2016, S.2124, doi:10.3390/ijms17122124 (mdpi.com [abgerufen am 12. April 2021]).
Diana Maria Chitimus, Mihaela Roxana Popescu, Suzana Elena Voiculescu, Anca Maria Panaitescu, Bogdan Pavel: Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. In: Biomolecules. Band10, Nr.9, 20. August 2020, S.1211, doi:10.3390/biom10091211.
Veronika Butterweck, Axel Brattstroem, Oliver Grundmann, Uwe Koetter: Hypothermic effects of hops are antagonized with the competitive melatonin receptor antagonist luzindole in mice. In: Journal of Pharmacy and Pharmacology. Band59, Nr.4, 18. Februar 2010, S.549–552, doi:10.1211/jpp.59.4.0009.
Dun‐Xian Tan, Lucien C. Manchester, Maria P. Terron, Luis J. Flores, Russel J. Reiter: One molecule, many derivatives: A never‐ending interaction of melatonin with reactive oxygen and nitrogen species? In: Journal of Pineal Research. Band42, Nr.1, Januar 2007, S.28–42, doi:10.1111/j.1600-079X.2006.00407.x.
Rüdiger Hardeland: Antioxidative Protection by Melatonin: Multiplicity of Mechanisms from Radical Detoxification to Radical Avoidance. In: Endocrine. Band27, Nr.2, 2005, S.119–130, doi:10.1385/ENDO:27:2:119.
Russel J. Reiter, Lucien C. Manchester, Dun-Xian Tan: Neurotoxins: Free Radical Mechanisms and Melatonin Protection. In: Current Neuropharmacology. Band8, Nr.3, 1. September 2010, S.194–210, doi:10.2174/157015910792246236.
Burkhard Poeggeler, Seppo Saarela, Russel J. Reiter, Dun‐Xian Tan, Li‐Dun Chen, Lucien C. Manchester, Lornell R. Barlow‐Walden: Melatonin—A Highly Potent Endogenous Radical Scavenger and Electron Donor: New Aspects of the Oxidation Chemistry of this Indole Accessed in vitro a. In: Annals of the New York Academy of Sciences. Band738, Nr.1, November 1994, S.419–420, doi:10.1111/j.1749-6632.1994.tb21831.x.
Carlo Pieri, Maurizio Marra, Fausto Moroni, Rina Recchioni, Fiorella Marcheselli: Melatonin: A peroxyl radical scavenger more effective than vitamin E. In: Life Sciences. Band55, Nr.15, Januar 1994, S.PL271–PL276, doi:10.1016/0024-3205(94)00666-0.
D.A. Lowes, N.R. Webster, M.P. Murphy, H.F. Galley: Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. In: British Journal of Anaesthesia. Band110, Nr.3, März 2013, S.472–480, doi:10.1093/bja/aes577.
Edward Mills, Ping Wu, Dugald Seely, Gordon Guyatt: Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta‐analysis. In: Journal of Pineal Research. Band39, Nr.4, November 2005, S.360–366, doi:10.1111/j.1600-079X.2005.00258.x.
Saad Abdul-Rehman Hussain, Ihab Ibrahim Al-Khalifa, Nizar Abdullatif Jasim, Faiq Isho Gorial: Adjuvant use of melatonin for treatment of fibromyalgia: Melatonin in fibromyalgia. In: Journal of Pineal Research. Band50, Nr.3, April 2011, S.267–271, doi:10.1111/j.1600-079X.2010.00836.x.
Xiao Meng, Ya Li, Sha Li, Yue Zhou, Ren-You Gan: Dietary Sources and Bioactivities of Melatonin. In: Nutrients. Band9, Nr.4, 7. April 2017, doi:10.3390/nu9040367.
M. Valtonen, L. Niskanen, A-P Kangas, T. Koskinen: Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects. In: Nordic Journal of Psychiatry. Band59, Nr.3, Juni 2005, S.217–221, doi:10.1080/08039480510023034.
Irene Joy I. dela Peña, Eunyoung Hong, June Bryan de la Peña, Hee Jin Kim, Chrislean Jun Botanas, Ye Seul Hong, Ye Seul Hwang, Byoung Seok Moon, Jae Hoon Cheong: Milk Collected at Night Induces Sedative and Anxiolytic-Like Effects and Augments Pentobarbital-Induced Sleeping Behavior in Mice. In: Journal of Medicinal Food. Band18, Nr.11, November 2015, S.1255–1261, doi:10.1089/jmf.2015.3448.
Silvia Miano, Pasquale Parisi, Andrea Pelliccia, Anna Luchetti, Maria Chiara Paolino, Maria Pia Villa: Melatonin to prevent migraine or tension-type headache in children. In: Neurological Sciences. Band29, Nr.4, September 2008, S.285–287, doi:10.1007/s10072-008-0983-5.
T.W. Fischer, G. Burmeister, H.W. Schmidt, P. Elsner: Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. In: British Journal of Dermatology. Band150, Nr.2, Februar 2004, S.341–345, doi:10.1111/j.1365-2133.2004.05685.x.
Roberto Valcavi, Michele Zini, Georges J. Maestroni, Ario Conti, Italo Portioli: Melatonin stimulates growth hormone secretion through pathways other than the growth hormone‐releasing hormone. In: Clinical Endocrinology. Band39, Nr.2, August 1993, S.193–199, doi:10.1111/j.1365-2265.1993.tb01773.x.
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA): Scientific Opinion on the substantiation of health claims related to melatonin and alleviation of subjective feelings of jet lag (ID 1953), and reduction of sleep onset latency, and improvement of sleep quality (ID 1953) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. In: EFSA Journal. Band8, Nr.2, Februar 2010, doi:10.2903/j.efsa.2010.1467.
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA): Scientific Opinion on the substantiation of a health claim related to melatonin and reduction of sleep onset latency (ID 1698, 1780, 4080) pursuant to Article 13(1) of Regulation (EC) No 1924/2006: Melatonin and reduction of sleep onset latency. In: EFSA Journal. Band9, Nr.6, Juni 2011, S.2241, doi:10.2903/j.efsa.2011.2241.
Alan G. Wade, Gordon Crawford, Ian Ford, Alex McConnachie, Tali Nir, Moshe Laudon, Nava Zisapel: Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response. In: Current Medical Research and Opinion. Band27, Nr.1, 1. Januar 2011, S.87–98, doi:10.1185/03007995.2010.537317.
Remy Luthringer, Muriel Muzet, Nava Zisapel, Luc Staner: The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia:. In: International Clinical Psychopharmacology. Band24, Nr.5, September 2009, S.239–249, doi:10.1097/YIC.0b013e32832e9b08.
Patrick Lemoine, Tali Nir, Moshe Laudon, Nava Zisapel: Prolonged‐release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. In: Journal of Sleep Research. Band16, Nr.4, Dezember 2007, S.372–380, doi:10.1111/j.1365-2869.2007.00613.x.
Alan G. Wade, Ian Ford, Gordon Crawford, Alex McConnachie, Tali Nir, Moshe Laudon, Nava Zisapel: Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. In: BMC Medicine. Band8, Nr.1, 16. August 2010, S.51, doi:10.1186/1741-7015-8-51.
Nina Buscemi, Ben Vandermeer, Nicola Hooton, Rena Pandya, Lisa Tjosvold, Lisa Hartling, Sunita Vohra, Terry P Klassen, Glen Baker: Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. In: The BMJ. Band332, Nr.7538, 18. Februar 2006, S.385–393, doi:10.1136/bmj.38731.532766.F6.
P. Levallois: Effects of Electric and Magnetic Fields from High-power Lines on Female Urinary Excretion of 6-Sulfatoxymelatonin. In: American Journal of Epidemiology. Band154, Nr.7, 1. Oktober 2001, S.601–609, doi:10.1093/aje/154.7.601.
Dominik H. Pfluger, Christoph E. Minder: Effects of exposure to 16.7 Hz magnetic fields on urinary 6‐hydroxymelatonin sulfate excretion of Swiss railway workers. In: Journal of Pineal Research. Band21, Nr.2, September 1996, S.91–100, doi:10.1111/j.1600-079X.1996.tb00275.x.
D.K. Lahiri, D. Davis, M. Adkins, J.I. Nurnberger: Factors That Influence Radioimmunoassay of Human Plasma Melatonin: A Modified Column Procedure to Eliminate Interference. In: Biochemical Medicine and Metabolic Biology. Band49, Nr.1, Februar 1993, S.36–50, doi:10.1006/bmmb.1993.1004.
S. J. Konturek, P. C. Konturek, T. Brzozowski, G. A. Bubenik: Role of melatonin in upper gastrointestinal tract. In: J. Physiol. Pharmacol. 58 Suppl 6, Dezember 2007, S.23–52, PMID 18212399 (jpp.krakow.pl [PDF]).
mdpi.com
Dun-Xian Tan, Lucien Manchester, Lilan Qin, Russel Reiter: Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics. In: International Journal of Molecular Sciences. Band17, Nr.12, 16. Dezember 2016, S.2124, doi:10.3390/ijms17122124 (mdpi.com [abgerufen am 12. April 2021]).
merckmillipore.com
Datenblatt Melatonin bei Merck, abgerufen am 19. Januar 2011.
nih.gov
ncbi.nlm.nih.gov
A. A. Borbély: A two process model of sleep regulation. In: Human Neurobiology. Band1, Nr.3, 1982, S.195–204, PMID 7185792.
S. J. Konturek, P. C. Konturek, T. Brzozowski, G. A. Bubenik: Role of melatonin in upper gastrointestinal tract. In: J. Physiol. Pharmacol. 58 Suppl 6, Dezember 2007, S.23–52, PMID 18212399 (jpp.krakow.pl [PDF]).
Russel J. Reiter, Dun-Xian Tan, Juan C. Mayo, Rosa M. Sainz, Josefa Leon, Zbigniew Czarnocki: Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. In: Acta Biochimica Polonica. Band50, Nr.4, 2003, S.1129–1146, PMID 14740000.